中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共69条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe;  Zhang, Qingyuan;  Liberati, Anna Marina;  Cao, Junning;  Yang, Haiyan;  Hao, Siguo;  Hu, Jianda;  Zhou, Keshu;  Petrini, Mario;  Russo, Filomena;  Zhang, Huilai;  Sang, Wei;  Ji, Jie;  Ferreri, Andres Jose Maria;  Damaj, Gandhi Laurent;  Liu, Hui;  Zhang, Wei;  Ke, Xiaoyan;  Ghiggi, Chiara;  Huang, Sha;  Li, Xiaotong;  Yao, Hui;  Paik, Jason;  Noveotny, William;  Zhou, Wenxiao;  Zhu, Hongji;  Zinzani, Pier Luigi
收藏  |  浏览/下载：29/0  |  提交时间：2023/11/10
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi;  Xu, Xiuxiu;  Tang, Wanxiangfu;  Ou, Qiuxiang;  Bao, Hua;  Wu, Xue;  Shao, Yang;  Xing, Minyan;  Zhang, Yixiang;  Wang, Yuezhen
收藏  |  浏览/下载：39/0  |  提交时间：2022/12/23
HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Fan, Ying;  Qin, Jing;  Han, Na;  Lu, Hongyang
收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23
Leptomeningeal metastasis (LM)  cerebrospinal fluid  HER2 exon 20 insertion mutations  poziotinib  case report  
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Lin, Yuxin;  Zhu, Wei;  Wu, Bingchen;  Lan, Huiyin
收藏  |  浏览/下载：46/0  |  提交时间：2022/05/16
Sarcoid-like reaction  immune checkpoint inhibitor  Toripalimab  PD-1  case report  
Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Xu, Xiaoqing;  Li, Jingjing;  Gao, Yiding;  Lv, Wangxia;  Wei, Qing;  Tang, Xiaowan;  Hu, Jinlin;  Yuan, Xing;  Wu, Wei;  Zhang, Lingnan;  Luo, Cong;  Chen, Lei;  Ying, Jieer;  Zhu, Xiu;  Xu, Qi
收藏  |  浏览/下载：47/0  |  提交时间：2022/05/16
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao;  Yu, Haifeng;  Guo, Na;  Li, Cong;  Peng, Shuailing;  Dong, Xiaowu;  Yang, Haiyan;  Wu, Meijuan
收藏  |  浏览/下载：64/0  |  提交时间：2022/02/14
Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment  
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma 期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 卷号: 8
作者:  Fan, Ying;  Shan, Qianyun;  Gong, Jiali;  Qin, Jing;  Lu, Hongyang
收藏  |  浏览/下载：56/0  |  提交时间：2022/01/10
PPLELC  clinical characteristics  molecular characteristics  immunotherapy  PD-L1  TMB  
If small molecules immunotherapy comes, can the prime be far behind? 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218
作者:  Zhang, Jingyu;  Zhang, Yu;  Qu, Bingxue;  Yang, Haiyan;  Hu, Shengquan;  Dong, Xiaowu
收藏  |  浏览/下载：55/0  |  提交时间：2021/06/15
Cancer immunotherapy  Small molecule inhibitors  Combination therapy  Tumor microenvironment  
Immune Microenvironment Features and Efficacy of PD-1/PD-L1 Blockade in Non-Small-Cell Lung Cancer Patients with EGFR or HER2 Exon 20 Insertions 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  Chen, K.;  Xu, Y.;  Huang, Z.;  Yu, X.;  Fan, Y.
收藏  |  浏览/下载：56/0  |  提交时间：2021/05/17
EGFR  HER2  Immunotherapy  
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Mao, Xinru;  Jin, Ren'an;  Zeng, Yu;  Li, Qinglin;  Wang, Jianbo;  Li, Yang;  Zhang, Yongchang;  Yang, Nong
收藏  |  浏览/下载：49/0  |  提交时间：2021/03/15
Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer